Soluble Terminal Complement Complex (sC5b-9) Antikörper
sC5b-9
Reaktivität: Human
FACS, IHC (fro), WB, ELISA
Wirt: Maus
Monoclonal
3R2-0
unconjugated
(1 reference)-
- Target
- Soluble Terminal Complement Complex (sC5b-9)
- Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Unkonjugiert
-
Applikation
- Flow Cytometry (FACS), Immunohistochemistry (Frozen Sections) (IHC (fro)), Western Blotting (WB), ELISA
- Produktmerkmale
- Purified IgG
- Aufreinigung
- Purified
- Klon
- 3R2-0
- Isotyp
- IgG2b
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1.0 mg/mL
-
-
: "C5b-9 complement complex in autoimmune demyelination and multiple sclerosis: dual role in neuroinflammation and neuroprotection." in: Annals of medicine, Vol. 37, Issue 2, pp. 97-104, (2005) (PubMed).
-
: "C5b-9 complement complex in autoimmune demyelination and multiple sclerosis: dual role in neuroinflammation and neuroprotection." in: Annals of medicine, Vol. 37, Issue 2, pp. 97-104, (2005) (PubMed).
-
- Target
- Soluble Terminal Complement Complex (sC5b-9)
- Andere Bezeichnung
- Sc5b-9
-
Sie sind hier:
